CB1/β-Arrestin/CHO
CBP71391
询 价
索取protocol
产品描述
产品数据库
I. Background | |
The cannabinoid receptor CNR1 is Gs-coupled GPCRs expressed in primarily CNS and some peripheral neurones; particularly prevalent in basal ganglia, hippocampus, cerebellum, cerebral cortex and also presented in some non-neuronal cells and tissues, for example leukocytes and testis. A shorter human splice variant (411aa) has been identified in the brain and other tissues by reverse-transcriptase PCR but mRNA levels were less than 10-fold the levels of the longer isoform. The pharmacological characteristics of the isoforms are similar. | |
II. Introduction | |
Host Cell: |
CHO |
Stability: | 20 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Culture Medium: | F12k+10%FBS+5ug/ml puromycin+5ug/ml blasticidin |
Mycoplasma Status: | Negative |
Storage: | Liquid nitrogen immediately upon delivery |
Application(s): | Functional assay for CNR1 |
Transducer: | β-Arrestin |
Ⅲ. Description of Host Cell Line | |
Organism: | Hamster |
Tissue: | Ovary |
Morphology: | Epithelial |
Growth Properties: | Adherent |
Ⅳ. Representative Data | |
Figure 1. Recombinant CB1/β-Arrestin/CHO constitutively expressing CB1. |
|
Figure 2.Dose response of CP-55940 in CB1 β-Arrestin CHO-K1 Cell Line (C2) |
|
Figure 3.Inhibition of CP-55940-induced Beta-Arrestin Recruitment in CB1 Beta-Arrestin CHO-K1 Cells (C2). |